Key result
Olezarsen acts as an antisense drug that targets APOC3 mRNA to treat hypertriglyceridemia.
Answers are grounded in this paper and cite their sources.
This editorial describes the science behind olezarsen, an antisense drug targeting APOC3 mRNA for the treatment of hypertriglyceridemia.
Olezarsen, APOC3, and Hypertriglyceridemia This editorial describes the science behind an antisense drug targeting APOC3 mRNA to treat hypertriglyceridemia.
No takes yet. Share an insight, caveat, or question.
Gerald F. Watts (2024) studied this question. Olezarsen acts as an antisense drug that targets APOC3 mRNA to treat hypertriglyceridemia.
Synapse has enriched 10 related papers. Consider them for comparative context: